These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2411984)

  • 1. Inability of rat anaphylatoxin to induce histamine release in rats.
    Konno S; Tsurufuji S
    Jpn J Pharmacol; 1985 Jun; 38(2):185-93. PubMed ID: 2411984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the factor(s) involved in pathogenesis of zymosan-induced inflammation in rats.
    Konno S; Tsurufuji S
    Jpn J Pharmacol; 1985 Jun; 38(2):177-84. PubMed ID: 2411983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of a novel anticomplementary agent, K-76COONa, on the release of histamine induced by zymosan and compound 48/80.
    Konno S; Tsurufuji S
    Jpn J Pharmacol; 1985 May; 38(1):116-9. PubMed ID: 2410651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of heparin and aminoguanidine on anaphylatoxin activity in the guinea-pig.
    Sackeyfio AC; Hicks R
    Eur J Pharmacol; 1987 May; 137(1):131-4. PubMed ID: 2440703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
    Dias Da Silva W; Lepow IH
    J Exp Med; 1967 May; 125(5):921-46. PubMed ID: 4960742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated complement and anaphylatoxins increase the in vitro production of prostacyclin by rabbit aorta endothelium.
    Rampart M; Bult H; Herman AG
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):158-65. PubMed ID: 6346110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downward regulation of neutrophil infiltration by endogenous histamine without affecting vascular permeability responses in air-pouch-type carrageenin inflammation in rats.
    Hirasawa N; Watanabe M; Mue S; Tsurufuji S; Ohuchi K
    Inflammation; 1991 Apr; 15(2):117-26. PubMed ID: 1712757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.
    Kings M; Nydegger UE; de Weck AL
    Immunology; 1984 Jan; 51(1):123-31. PubMed ID: 6197357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom.
    Damerau B; Lege L; Oldigs HD; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):141-56. PubMed ID: 49854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of the C4a anaphylatoxin from rat.
    Cui L; Ferreri K; Hugli TE
    Mol Immunol; 1988 Jul; 25(7):663-71. PubMed ID: 3262196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum.
    Edens RE; Linhardt RJ; Bell CS; Weiler JM
    Immunopharmacology; 1994; 27(2):145-53. PubMed ID: 8014028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for phospholipase-arachidonic acid involvement in anaphylatoxin-induced smooth muscle contraction and histamine release from mast cells.
    Pison U; Theobald K; Bohn A; Kunau HW; König W
    Monogr Allergy; 1983; 18():206-10. PubMed ID: 6196626
    [No Abstract]   [Full Text] [Related]  

  • 18. C5a-induced histamine release. Species specificity.
    Regal JF; Hardy TM; Casey FB; Chakrin LW
    Int Arch Allergy Appl Immunol; 1983; 72(4):362-5. PubMed ID: 6196303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement.
    Henson PM; Cochrane CG
    J Exp Med; 1969 Jan; 129(1):167-84. PubMed ID: 4178112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of antianaphylactic action of beta-agonists in allergic inflammation of air pouch type in rats.
    Ohuchi K; Hirasawa N; Takeda H; Asano K; Watanabe M; Tsurufuji S
    Int Arch Allergy Appl Immunol; 1987; 82(1):26-32. PubMed ID: 2879797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.